Profusa, Inc Common Stock

Yahoo Finance • 2 months ago

Profusa Announces 1-for-75 Reverse Stock Split

Profusa, Inc. BERKELEY, California, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital health company pioneering a next-generation technology platform enabling the conti... Full story

Yahoo Finance • 4 months ago

Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026

Study conducted at US sites evaluates LumeeTMin peripheral artery disease (PAD) patients BERKELEY, Calif, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital health co... Full story

Yahoo Finance • 4 months ago

Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025

Study evaluates Lumee™ Oxygen tissue monitoring platform with transcutaneous partial pressure of oxygen (tcpO₂) in peripheral artery disease patients BERKELEY, Calif, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “C... Full story

Yahoo Finance • 4 months ago

Profusa Announces Third Quarter Business and Financial Highlights

Recapitalization reduced net debt to $14 million as of October 31; achieved key milestones to deliver potential 2026 revenue target BERKELEY, Calif, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq:... Full story

Yahoo Finance • 5 months ago

Profusa Outlines Potential Path to $250 Million Revenue by 2030, Driven by Sequential Lumee™ Oxygen and Glucose Monitoring Launches

EU commercialization expected in early 2026; U.S. entry and expanded indications to follow as digital-health pioneer advances tissue-integrated biosensor platform BERKELEY, Calif, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profu... Full story

Yahoo Finance • 5 months ago

Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026

Achieved key operational milestones establishing manufacturing capabilities to supply more than 2x the products required to achieve 2026 revenue targets BERKELEY, Calif, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the... Full story

Yahoo Finance • 5 months ago

Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe

Initial target markets for commercialization include Germany, the Benelux countries, Austria, the United Kingdom, and Scandinavia Expands distributor channel coverage to ~35% of European Union population with ~300,000 annual endovascular... Full story

Yahoo Finance • 6 months ago

Profusa invests additional $1 million in digital treasury assets

* Profusa (NASDAQ:PFSA [https://seekingalpha.com/symbol/PFSA]) announced on Tuesday its second $1 million investment in digital treasury assets to hedge against macroeconomic uncertainties, in line with the company’s treasury management... Full story

Yahoo Finance • 6 months ago

Profusa Invests Additional $1 Million in Digital Treasury Assets

BERKELEY, Calif, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital health company pioneering a next-generation technology platform enabling the continuous monitoring... Full story

Yahoo Finance • 6 months ago

Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base

Pr. Yann Gouëffic and affiliates (FRANCE-PAD) cover ~8% of all CLTI cases in France BERKELEY, Calif, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital health company... Full story

Yahoo Finance • 7 months ago

Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring

Company expects early 2026 rollout in EEA; physician portal combines Lumee™ oxygen monitoring with NVIDIA NeMo to deliver AI-driven clinical workflows BERKELEY, Calif, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the... Full story

Yahoo Finance • 7 months ago

Profusa Adds Head of Vascular Surgery Department at AZ Sint Blasius Hospital, Belgium to Growing Customer Base

Internationally recognized vascular surgeon, Dr. Koen Deloose provides patient access to latest innovative treatments and personalized care BERKELEY, Calif, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”)... Full story

Yahoo Finance • 7 months ago

Profusa Announces Commercial and Clinical Collaboration with Head of Angiography, Medical University of Graz, Austria

Led by Prof. Dr. Marianne Brodmann, PI of clinical studies for the Lumee™ Oxygen CE Mark, collaboration includes practice adoption and platform integration in cases and clinical study programs BERKELEY, Calif, Aug. 27, 2025 (GLOBE NEWSW... Full story

Yahoo Finance • 7 months ago

Profusa amends purchase agreement and note terms for convertible debt tranches

Profusa, Inc. (NASDAQ:PFSA), a microcap company with a market value of $16.48 million, announced Monday that it has amended its Securities Purchase Agreement and Senior Secured Convertible Promissory Note with Ascent Partners Fund LLC, ori... Full story

Yahoo Finance • 7 months ago

Profusa Welcomes Former Acting U.S. Veterans Affairs Secretary Peter O’Rourke as Lead Independent Director; Adds Seasoned Finance Executive Fred Knechtel as CFO

Board addition served in the Trump Administration, overseeing 1,300 facilities serving more than 9 million veterans; New CFO has led finance and operations at companies including Northrop Grumman, Stanley Black & Decker, and DuPont Berkel... Full story

Yahoo Finance • 8 months ago

Profusa shares strategy update as it transitions to public company

BERKELEY - Profusa, Inc. (NASDAQ:PFSA), a digital health company focused on continuous biochemistry monitoring technology, outlined its growth strategy following its recent Nasdaq listing on July 14, according to a shareholder letter relea... Full story

Yahoo Finance • 8 months ago

Profusa, Inc. Provides Strategy Overview and Business Update for Investors

BERKELEY, Calif, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monito... Full story

Yahoo Finance • 8 months ago

Profusa Secures Lumee™ Oxygen Platform Distributor in Spain

BERKELEY, Calif, July 31, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitor... Full story

Yahoo Finance • 8 months ago

Profusa Announces $100 Million Equity Line of Credit to Initiate Bitcoin Treasury Strategy

BERKELEY, Calif, July 21, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monito... Full story